FIELD: medicine. SUBSTANCE: described are new sulfonamides of general formula I: wherein R1 is hydrogen, lower alkyl; R2 is hydrogen, lower alkyl; R3 is hydrogen, lower alkyl; R2 and R3 are together methylene-dioxy, ethylenedioxy or ispropylidedinoxy: R4 is hydrogen, lower alkyl, lower alkoxy, lower alkylthio, oxylower alkyl, oxylower alkoxy, oxylower alkoxy-lower alkyl, oxylower alkoxy-lower alkoxy, alkoxy-lower alkyl, alkoxy-lower alkoxy, amino-lower alkyl, lower alkyl amino-lower alkyl, morpholino, 2-pirimidinyl, CHO, -CH2OH or -CH2Cl;; R5-R8 are hydrogen, halogen, lower alkoxy, lower alkylthio; X is -O- or -S-; Y is -CHO; C1-4 alkyl, and cyclic ketals thereof, , OR12, R9 are hydrogen or C1-4 alkyl; R12 is C1-4 -$ alkyl; or -(CH2)0-4-aryl; Z is -O-, het is heterocyclic residue such as thienyl, pyridinyl, hal is halogen, and n is 0 or 1. Compounds are essentially endotolialic receptor inhibitors and are useful for treating disease associated with processes which promote narrowing of vessels. EFFECT: improved properties of new sulfonamides. 13 cl, 56 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
BENZENESULFONAMIDE DERIVATIVES OF PYRIMIDINE OR THEIR SALTS, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES ASSOCIATED WITH ENDOTHELIN ACTIVITY | 1992 |
|
RU2086544C1 |
SULPHONAMIDE DERIVATIVES | 2005 |
|
RU2378258C2 |
SULFONAMIDES AND PHARMACEUTICAL PREPARATION | 1995 |
|
RU2162084C2 |
ARYLCYCLOHEXYL ESTERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | 2009 |
|
RU2507205C2 |
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
PYRAZOLPYRIMIDINE DERIVATIVES | 2005 |
|
RU2378277C2 |
OXAZOLINE DERIVATIVES FOR TREATING CNS DISORDERS | 2010 |
|
RU2569887C2 |
TRIAZOLO (4,3-a) 1,4 BENZO DIAZEPINES AND THRENO (3,2 | 1992 |
|
RU2094436C1 |
PYRIDINE AND PYRIMIDINE DERIVATIVES AS mGluR2 ANTAGONISTS | 2007 |
|
RU2451673C2 |
NEW DOSAGE FORM | 2006 |
|
RU2431473C2 |
Authors
Dates
2000-09-20—Published
1993-12-07—Filed